Preprint Communication Version 1 Preserved in Portico This version is not peer-reviewed

Analysis of Transcriptomics Data from COVID-19 Patients: Pilot Research

Version 1 : Received: 1 June 2023 / Approved: 2 June 2023 / Online: 2 June 2023 (11:12:22 CEST)

A peer-reviewed article of this Preprint also exists.

Hadzega, D.; Babisova, K.; Hyblova, M.; Janostiakova, N.; Sabaka, P.; Janega, P.; Minarik, G. Analysis of Transcriptomics Data from COVID-19 Patients: A Pilot Research. Folia Microbiologica 2024, doi:10.1007/s12223-024-01130-x. Hadzega, D.; Babisova, K.; Hyblova, M.; Janostiakova, N.; Sabaka, P.; Janega, P.; Minarik, G. Analysis of Transcriptomics Data from COVID-19 Patients: A Pilot Research. Folia Microbiologica 2024, doi:10.1007/s12223-024-01130-x.

Abstract

During the infection by SARS-CoV-2, the virus is changing infected host cell into its own factory producing new viral particles. As infection progresses, infected cell undergoes many changes in various pathways. One of the events caused by changes is cytokine storm, which leads to the severe symptoms. In this study, we investigated transcriptomic changes caused by COVID-19 disease using RNA-seq data obtained from COVID-19-positive patients and COVID-19-negative donors. RNA-seq data were collected for the purpose of identification of potential biomarkers associated with a different course of the disease. Here, the first datasets of 96 samples were analyzed to validate the methods. The aim of this publication is to report pilot results. In search of potential biomarkers associated with different disease severity, we performed differential expression analysis of human transcriptome, focusing on COVID-19 positivity and symptom severity. Since we detected plenty of potential biomarkers, we performed KEGG enrichment analysis to get better view of altered pathways. Results show, that affected were pathways related to immune processes and response to infection, also multiple signaling pathways, while most of them were also reported to be influenced by SARS-CoV-2 infection in previous studies.

Keywords

RNA-seq; COVID-19; SARS-CoV-2; gene enrichment analysis; enriched pathways; differentially expressed genes; transcriptomics

Subject

Biology and Life Sciences, Immunology and Microbiology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.